Chung et al. identified three mechanisms through which BFT promotes CRC tumorigenesis: 1) IL-17 binding to IL-17R, 2) activation of STAT3, and 3) activation of the NF-κB pathway (Chung et al., 2018). Here, NFKB1 is linked to colorectal carcinoma.